Targeted Delivery of Quercetin to the Brain via a Modified Polymeric Nanocarrier
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.202500503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Priyanshu Bhadane und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, School of Pharmacy & Technology Management, Mukesh Patel Technology Park, SVKM's NMIMS University, Shirpur, I…. Hauptthemen laut MEDLINE: Quercetin, Nanoparticles, Drug Carriers, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Rajiv Gandhi Science and Technology Commission, Government of Maharashtra.
Abstract (Originalsprache)
Quercetin (Qt) exhibits significant neuroprotective potential in Alzheimer's disease; however, its clinical translation is limited by poor solubility, low permeability, and inadequate brain bioavailability. In this study, a modified polymeric nanocarrier was developed to enhance Qt delivery to the brain. Polyethyleneimine (PEI) was conjugated with polyethylene glycol (PEG) and further functionalized with phenylalanine to reduce PEI‐associated toxicity and improve brain‐targeting efficiency. Successful polymer synthesis was confirmed by FT–IR spectroscopy, showing characteristic S─S bond formation at 790 cm − 1 , mass spectrometry (m/z 1087.3), and differential scanning calorimetry. Nanoparticles were optimized using a Quality by Design approach, yielding an experimental particle size of 161.4 ± 1.10 nm, zeta potential of 15.9 ± 2.5 mV, and high entrapment efficiencies of 84.21 % and 86.74 % for Qt‐PEI‐Np and Qt‐PEI‐PEG‐S‐S‐AA‐Np, respectively. SEM analysis revealed spherical nanoparticles with nanoscale surface roughness and good stability. In vitro release studies demonstrated sustained Qt release (98 % over 48 h). MTT assays and cytokine analysis (TNF‐α, IL‐1β, IL‐6) confirmed biocompatibility. Enhanced intestinal permeability, absence of hippocampal toxicity, and effective BBB transport further support the potential of this nanocarrier for targeted neurotherapeutic delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, School of Pharmacy & Technology Management, Mukesh Patel Technology Park, SVKM's NMIMS University, Shirpur, India.
- Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed to Be University, Mumbai, Maharashtra, India.
- Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India.
- Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
ORCID-Profile: Aniket Khairnar, Kalpana Pandya, Anup Naha, Dileep Kumar, K A Abutwaibe, Devendra Kumar
Förderung
- Rajiv Gandhi Science and Technology Commission, Government of Maharashtra
Zitieren
APA
Bhadane, P., Khairnar, A., Pandya, K., Naha, A., Kumar, D., Abutwaibe, K. A., Desai, J., Bombatkar, N., Rajput, P., & Kumar, D. (2026). Targeted Delivery of Quercetin to the Brain via a Modified Polymeric Nanocarrier. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202500503
Vancouver
Bhadane P, Khairnar A, Pandya K, Naha A, Kumar D, Abutwaibe KA, et al. Targeted Delivery of Quercetin to the Brain via a Modified Polymeric Nanocarrier. Macromolecular Bioscience. 2026. doi:10.1002/mabi.202500503
BibTeX
@article{Bhadane2026,
author = {Bhadane, Priyanshu and Khairnar, Aniket and Pandya, Kalpana and Naha, Anup and Kumar, Dileep and Abutwaibe, K A and Desai, Jiya and Bombatkar, Nilesh and Rajput, Prabha and Kumar, Devendra},
title = {Targeted Delivery of Quercetin to the Brain via a Modified Polymeric Nanocarrier},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.202500503}
}
EUVIMED